Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb;44(2):197-206.
doi: 10.1002/phar.2895. Epub 2023 Nov 28.

Methenamine for urinary tract infection prophylaxis: A systematic review

Jian Mei Li  1 , Leon E Cosler  1 , Elizabeth P Harausz  2   3 , Courtney E Myers  2   3 , Wesley D Kufel  1   2   3
Affiliations

Methenamine for urinary tract infection prophylaxis: A systematic review

Jian Mei Li et al. Pharmacotherapy. 2024 Feb.

Abstract

Urinary tract infections (UTIs) commonly affect many patient populations. Recurrent UTIs (rUTIs) can be particularly problematic and lead to potential hospitalizations, multiple antibiotic courses, and have a potential negative impact on quality of life. To prevent UTIs, antibiotics are frequently used for prophylaxis; however, antibiotic prophylaxis has notable untoward consequences including but not limited to potential adverse effects and development of antibiotic resistance. Methenamine, an antiseptic agent initially available in 1967, has re-emerged as a potential option for UTI prophylaxis in various populations, including older adults and renal transplant recipients. The objective of this systematic review was to evaluate the clinical effectiveness and safety of methenamine for UTI prophylaxis. A systematic review following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidance was performed. A PubMed, Embase, and Cochrane library search was conducted to identify relevant English-language studies evaluating methenamine for UTI prophylaxis including randomized controlled trials, case-control studies, and meta-analyses through June 2023. Articles were excluded if the studies did not primarily describe or evaluate methenamine for UTI prophylaxis, were commentaries/viewpoints articles, point prevalence studies, review articles, studies that evaluated methenamine used with another agent, and any duplicate publications from searched databases. A total of 11 articles were identified for inclusion. This systematic review suggests methenamine generally appears to be an effective and well-tolerated antibiotic-sparing option for UTI prophylaxis. Furthermore, the pharmacology, dosage and formulation, warnings, precautions, and safety considerations of methenamine that provide potential clinical considerations regarding its use for UTI prophylaxis are described. Further studies are needed to evaluate the clinical utility of methenamine for UTI prophylaxis.

Keywords: antiseptic; methenamine; prevention; prophylaxis; urinary tract infection.

PubMed Disclaimer

References

REFERENCES

    1. MacRae V, Holland S, MacLeod R. Diagnosing, managing and preventing urinary tract infections in older people with dementia in hospital. Nurs Older People. 2022;34(3):28-33.
    1. Rowe TA, Juthani-Mehta M. Diagnosis and management of urinary tract infection in older adults. Infect Dis Clin North Am. 2014;28(1):75-89.
    1. Snellings MS, Linnebur SA, Pearson SM, Wallace JI, Saseen JJ, Fixen DR. Effectiveness of Methenamine for UTI prevention in older adults. Ann Pharmacother. 2020;54(4):359-363.
    1. Sihra N, Goodman A, Zakri R, Sahai A, Malde S. Nonantibiotic prevention and management of recurrent urinary tract infection. Nat Rev Urol. 2018;15(12):750-776.
    1. Nicolle LE, Gupta K, Bradley SF, et al. Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the infectious diseases Society of America. Clin Infect Dis. 2019;68(10):e83-e110.

Publication types

MeSH terms

LinkOut - more resources